Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040493 · ClinicalTrials.gov registry record · NA
Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer
A NA study, sponsored by Xoft.
- Terminated
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT02040493 is a NA study that was terminated before completion, run by Xoft. The registered enrollment target is 75 participants.
The verdict
NCT02040493, a NA study, was terminated before completion, sponsored by Xoft.
- TERMINATED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This is a physician sponsored multi-center, non-randomized, prospectively enrolling data collection study of patients with early stage breast cancer treated with electronic brachytherapy at the time of surgical resection of the cancer in the operating room. The radiation therapy treatments will be administered with electronic brachytherapy using the FDA cleared Xoft Axxent System.
Interventions
- RADIATION Intra-operative radiation therapy (IORT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2008-09 |
| Est. Completion | 2016-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02040493
The ClinicalTrials.gov registry entry for NCT02040493 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xoft, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra-operative radiation therapy (IORT) is the first listed.
NCT02040493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02040493 about?
NCT02040493 is a clinical study titled "Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer". This is a physician sponsored multi-center, non-randomized, prospectively enrolling data collection study of patients with early stage breast cancer treated with electronic brachytherapy at the time of surgical resection of the cancer in the operating room. The radiation therapy treatments will be a...
What is the current status of trial NCT02040493?
This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2008-09. Estimated completion is 2016-10-04.
What interventions are being tested in trial NCT02040493?
The interventions under investigation include: Intra-operative radiation therapy (IORT) (RADIATION).
Who is sponsoring clinical trial NCT02040493?
This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.